Gastroenterology services proved their strength in the latter half of 2020 and are primed to stay hot in the coming years. As we describe in this new report, several market tailwinds make gastroenterology services an appealing option for investors.
Since May 2020, U.S. gastroenterology volume is up nearly 30%.1 And although there was a decrease in deals in the wake of COVID-19, both platform and add-on acquisitions accelerated again at the end of 2020 and at the beginning of this year.
The gastroenterology market’s strength isn’t surprising when you consider that between 60 and 70 million Americans are estimated to suffer from digestive diseases.2 As the country goes forward in the wake of the pandemic, this market will be ripe with investment opportunities. In fact, both independent physician groups and large, privately owned provider groups may be looking for long-term support from either private equity or another platform.
In this new report, the Harris Williams Healthcare & Life Sciences Group discusses the landscape of the gastroenterology services market, including:
- Platform dynamics
- Impact of COVID-19
- Leading companies
- Key metrics and market statistics
To access this report, please complete the form below.